Alume Biosciences Granted FDA Fast Track Designation Of ...
Fast Track designation aids Alume Biosciences in expediting ALM-488's development, a fluorescent peptide-dye for intraoperative nerve visualization, highlighting its potential in surgeries where nerves are at risk. ALM-488 binds to nerves, illuminating them in real-time, with applications in various surgical fields. Alume, founded in 2017, focuses on nerve-specific targeting molecules.
Reference News
Fast Track designation aids Alume Biosciences in expediting ALM-488's development, a fluorescent peptide-dye for intraoperative nerve visualization, highlighting its potential in surgeries where nerves are at risk. ALM-488 binds to nerves, illuminating them in real-time, with applications in various surgical fields. Alume, founded in 2017, focuses on nerve-specific targeting molecules.